Bristol-Myers seeks HIV drug approval in Europe
Pharmaceutical firm Bristol-Myers Squibb Co. on Wednesday said it submitted an application to market in Europe its new drug to treat the HIV infection and its deadly successor AIDS. The experimental
Pharmaceutical firm Bristol-Myers Squibb Co. on Wednesday said it submitted an application to market in Europe its new drug to treat the HIV infection and its deadly successor AIDS. The experimental